Livongo Health tops targets, raises $355M in upsized IPO
July 24, 2019 at 21:10 PM EDT
The Mountain View chronic illness management business sold about 2 million more shares than expected and is now valued at over $2.5 billion. That's more than double its last private valuation of about $805 million in April 2018.
